SCHEMBL27135013

SCHEMBL27135013

Cc1ccc(C(=O)OC2C(OC(=O)c3ccc(C)cc3)C3(C)CCC2(C)CC3)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN1A P35498 1/20 0.50
▸ SCN2A Q99250 1/20 0.50
▸ SCN3A Q9NY46 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.48
▸ ALDH1A1 P00352 6/20 0.44
▸ MAPT P10636 5/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ HPGD P15428 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ LMNA P02545 1/20 0.41
▸ CES2 O00748 1/20 0.41
▸ CES1 P23141 1/20 0.41
▸ RAB9A P51151 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ GAA P10253 2/20 0.40
▸ ESR1 P03372 1/20 0.40
▸ NR1I2 O75469 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27134203 0.89 ESR1 (0.42) SCN1ASCN2ASCN3ATDP1ALDH1A1
SCHEMBL27138253 0.89 ESR1 (0.42) SCN1ASCN2ASCN3ATDP1ALDH1A1
SCHEMBL27135064 0.87 SCN1A (0.41) SCN1ASCN2ASCN3ATDP1ALDH1A1
SCHEMBL27134058 0.84 GAA (0.55) TDP1KMT2ALMNAMEN1GAA
SCHEMBL27135056 0.82 SCN1A (0.54) SCN1ASCN2ASCN3AMAPTKMT2A
SCHEMBL27134271 0.80 GAA (0.51) TDP1KMT2ALMNAMEN1GAA
SCHEMBL27134258 0.80 GAA (0.51) TDP1KMT2ALMNAMEN1GAA
SCHEMBL27134072 0.75 GAA (0.47) TDP1KMT2ALMNAMEN1GAA
SCHEMBL9891376 0.74 SCN1A (0.75) SCN1ASCN2ASCN3ATDP1ALDH1A1
SCHEMBL4544916 0.74 SCN1A (0.75) SCN1ASCN2ASCN3ATDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067764-A1 SOLID TITANIUM CATALYST COMPONENT, OLEFIN POLYMERIZATION CATALYST, OLEFIN POLYMERIZATION METHOD, AND PROPYLENE POLYMER MITSUI CHEMICALS, INC. (JP) 2024-02-29 — — US disclosed
US-20240067597-A1 ESTER COMPOUND MITSUI CHEMICALS, INC. (JP) 2024-02-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067597-A1 ESTER COMPOUND PPT1, GPER1, TCP1 SCN1A 4025/4885SCN2A 4481/4885SCN3A 4509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback